The International Society for Stem Cell Research (ISSCR) has launched its 2026 Annual Meeting in Montréal, an event that unites thousands of experts across stem cell biology, regenerative medicine, and translational science. Spanning four days, the meeting highlights the cutting-edge advancements fueling progress in disease modeling, gene editing, and therapeutic development.
ISSCR 2026 serves as a vibrant platform for showcasing nearly 1,300 scientific posters and presentations that span the full spectrum of stem cell research. Attendees gain access to breakthrough discoveries, emerging technologies, and innovative methodologies shaping the future of biomedical science. The conference fosters interdisciplinary collaboration among scientists, clinicians, ethicists, and industry leaders, creating fertile ground for cross-pollination of ideas and accelerating translational impact.
The opening plenary, curated by ISSCR President Hideyuki Okano, set an inspiring tone by featuring pioneers whose research has fundamentally transformed the field. Nobel Laureate Shinya Yamanaka, whose identification of induced pluripotent stem cells (iPSCs) revolutionized regenerative medicine, underscored the transformative potential of reprogramming adult cells to a pluripotent state. This discovery laid the groundwork for novel approaches in personalized disease models and cell replacement therapies that continue advancing toward clinical application.
Another highlight included Madeline Lancaster’s presentation on brain organoids—three-dimensional cultures derived from stem cells that recapitulate human brain development. These models are invaluable for probing complex neurodevelopmental processes and uncovering mechanisms underlying neurological disorders, offering unprecedented insights into human brain evolution and pathology.
Yukiko Gotoh’s research shed light on the molecular circuits guiding neuronal specification and connectivity formation during mammalian brain development. Her findings contribute to an enhanced understanding of neurodevelopmental disorders, elucidating how disruptions to these pathways may lead to cognitive and behavioral phenotypes.
Feng Zhang, renowned for pioneering CRISPR genome-editing technologies, discussed innovations that enhance the precision and scope of genetic engineering in stem cell contexts. Such advancements open avenues for sophisticated gene-modulation therapies targeting neurological diseases, paving the way for personalized, cell-based interventions.
Throughout the conference, participants engage with state-of-the-art tools and emerging technologies showcased in the Exhibit and Poster Hall, offering a glimpse into next-generation platforms that promise to accelerate both basic research and clinical translation.
President Okano emphasized the ISSCR community’s shared commitment to advancing science responsibly, ensuring that transformative discoveries are ethically developed for global patient benefit. As stem cell science rapidly evolves, ISSCR 2026 exemplifies a critical nexus for innovation, dialogue, and collaboration essential to realizing the therapeutic promise of regenerative medicine.
For more details on the ISSCR 2026 meeting, visit www.isscr2026.org.
Subject of Research: Stem cell research, regenerative medicine, gene editing, neurodevelopmental biology
Article Title: ISSCR 2026 Unites Leading Minds to Drive Forward Stem Cell Science and Translational Innovation
News Publication Date: Not specified
Web References: www.isscr2026.org
Image Credits: ISSCR
Keywords: Stem cell research, regenerative medicine, induced pluripotent stem cells, brain organoids, CRISPR, neurodevelopment, translational medicine
